Delivery Order SPE2DB24D1021-SPE2DB25FEUBG

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,044.80, is for the delivery of Pediarix 0.5 ML syringes, a critical pediatric vaccine product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 27, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is valued at $1,960.94 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pediarix 0.5 ML syringes, a pediatric vaccine, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $5,147.52, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pediarix 0.5 ML syringes, a pediatric combination vaccine. This is a firm fixed-price delivery order contract with a completion date of January 2, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,124.10, is for the delivery of Pediarix 0.5 ML syringes, a pediatric vaccine product. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen is the prime contractor, and there is no indication of any major subcontractors. The contract is not set aside for any specific...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,018.05 firm fixed-price delivery order is for the supply of Pediarix 0.5 ML syringes, a pediatric combination vaccine. The contract has an ultimate completion date of November 13, 2024 and was awarded on November 12, 2024. This delivery order is placed against Amerisourcebergen's $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pediarix 0.5 ML syringes, a pediatric vaccine, with a ceiling value of $9,399.92 and a period of performance ending on January 3, 2025. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pediarix 0.5 ML Syringes, a pediatric vaccine, with a ceiling value of $5,416.13 and an ultimate completion date of May 17, 2024. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,086.24 firm fixed-price delivery order is for the supply of Pediarix 0.5 ML syringes, a pediatric combination vaccine. The contract has a completion date of June 28, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,019.62, is for the delivery of Pediarix 0.5 ML syringes, a vaccine product. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 4, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,238.36, is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine. The contract has an ultimate completion date of January 17, 2025 and utilizes a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEUBG
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,215.50, is for the delivery of Pediarix 0.5 ML syringes, a pediatric combination vaccine. The contract is a Firm Fixed Price Delivery Order with a completion date of February 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There is no set-aside designation on this specific contract award.

Generated 5/22/25, 8:34 PM